Product Information
CEPHALEXIN 250 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.7640 per EA under NDC 59651078301. Its NADAC has been published 90 times since Dec 4, 2024.
FDA first approved this application on Sep 27, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Cephalexin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651078301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEPHALEXINApproval Type
Generic (ANDA)
FDA Application
ANDA218817FDA Approved
9/27/2024
TE Code
AB
On Market Since
9/27/2024
Pharmacological Classes
Price Statistics
The NADAC for CEPHALEXIN 250 MG TABLET has been published 90 times since Dec 4, 2024, and over the history we have for it it has declined 12.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7640 per EA |
|---|---|
| All-time high | $0.9351 (Dec 10, 2025) |
| All-time low | $0.6858 (Apr 22, 2026) |
| 52-week high | $0.9351 |
| 52-week low | $0.6858 |
| Median price | $0.9106 |
| Average price | $0.8457 |
| Largest weekly change | -19.7% (Dec 17, 2025) |
| Weeks tracked | 90 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cephalexin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEPHALEXIN 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CEPHALEXIN 250 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.7640 per EA (NDC 59651078301), effective Aug 19, 2026.
How has the price of CEPHALEXIN 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for CEPHALEXIN 250 MG TABLET has declined 12.6%. It has been tracked across 90 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for CEPHALEXIN 250 MG TABLET?
Since Dec 4, 2024, the NADAC for CEPHALEXIN 250 MG TABLET has ranged from a low of $0.6858 (Apr 22, 2026) to a high of $0.9351 (Dec 10, 2025), with a median of $0.9106 per EA.
Are there cheaper alternatives to CEPHALEXIN 250 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CEPHALEXIN 250 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CEPHALEXIN 250 MG TABLET?
CEPHALEXIN 250 MG TABLET (NDC 59651078301) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.